Jack Slatton is a Senior majoring in Medicine, Health, and Society and Neuroscience. He worked with Dr. Mallory Hacker to identify common factors that encourage patients to continue receiving botulinum neurotoxin injections for the treatment of spasticity. Spasticity is a common movement disorder that can lead to increased muscle tone, involuntary movements, and pain or discomfort in the affected limbs. Botulinum neurotoxin is one of the most effective treatments for spasticity, and can help reduce feelings of pain and provide increased range of motion. In spite of this, discontinuation rates for neurotoxin injections are high; this study seeks to identify why patients continue treatment.